Abstract | In a mature, infectious HIV-1 virion, the viral genome is housed within a conical capsid core made from the viral capsid (CA) protein. The CA protein and the structure into which it assembles facilitate virtually every step of infection through a series of interactions with multiple host cell factors. This Review describes our understanding of the interactions between the viral capsid core and several cellular factors that enable efficient HIV-1 genome replication, timely core disassembly, nuclear import and the integration of the viral genome into the genome of the target cell. We then discuss how elucidating these interactions can reveal new targets for therapeutic interactions against HIV-1.
HIV-1 is the virus responsible for acquired immune deficiency syndrome (AIDS). HIV-1 is a lentivirus that infects cells of the immune system, specifically CD4 + T cells and macrophages; the gradual depletion of infected T cells leads to the development of AIDS in individuals who are not receiving antiretroviral therapy. Following viral attachment to the surface of the infected cell and fusion between the viral and host cell membranes, the HIV-1 conical capsid core -which houses the viral RNA genome -is released into the cytoplasm of the infected cell. The capsid core then traffics towards the nucleus while the viral RNA genome is reverse-transcribed into DNA. Notably, HIV-1 (and other primate lentiviruses, such as simian immunodeficiency virus (SIV)) have evolved the ability to traverse the nuclear envelope and enter the nucleus of non-dividing cells. In the nucleus, the viral genome becomes stably integrated into the genome of the target cell, where it directs the formation of progeny virions, which are ultimately released from the cell to infect new target cells (FIG. 1) .
It is increasingly appreciated that the viral capsid (CA) protein plays a much more critical part in many of these steps than previously thought, including having a crucial role in the nuclear import of the viral genome. This Review focuses on the events occurring during the early phase of the HIV-1 replication cycle -which includes the events from viral attachment to the host cell until viral integration into the host genome -focusing on the role of CA and the capsid core in mediating critical events during infection. We discuss models of viral uncoating, describe the cellular factors that are thought to interact with CA during HIV-1 infection and discuss how elucidating these interactions can be used to design new therapeutic strategies against HIV-1.
The HIV-1 capsid Any discussion on the role of the capsid during the early events of the viral life cycle can quickly become confusing because the term 'capsid' can refer to both the capsid core and the protein that assembles to form the core (CA). Here, we use 'CA' to describe the protein and 'capsid core' to describe the conical structure, which is a large assembly of CA and houses the viral genome.
Following release of an immature virion from an infected cell, the viral protease is activated and cleaves the approximately 5,000 molecules of Gag polyprotein (Gag) present in the immature viral particle into its primary constituents: matrix (MA) protein, CA, nucleocapsid (NC) protein and p6 peptide 1 . At this time, CA spontaneously assembles into the characteristic fullerene cone observed in HIV-1 virions, which houses the HIV genome, the viral replicative enzymes -reverse transcriptase and integrase -and some accessory proteins. This conical capsid core consists of approximately 1,500 CA monomers 1 , which are assembled predominantly into hexamers, with a few pentamers facilitating the curvature on the top and bottom of the core necessary to form a closed structure 2, 3 (FIG. 2) . The CA protein itself comprises two domains: an ~150-amino-acid-long amino-terminal domain (CA NTD ) and an ~80-aminoacid-long carboxy-terminal domain (CA CTD ). When CA is assembled into pentamers and hexamers, each CA NTD is located on the outer surface of the capsid core and each CA CTD is oriented towards the interior of the 
Antiretroviral therapy
Treatment using a combination of pharmacological inhibitors of viral enzymes (including reverse transcriptase, protease and, more recently, integrase), which together potently suppress viral replication, reduce viral load and prevent the development of acquired immune deficiency syndrome (AIDS) in patients with HIV.
Integrase
An enzyme that catalyses the integration of DNA segments with longer DNA chains. All retroviruses express an integrase enzyme, which is responsible for inserting the double-stranded DNA genome generated by reverse transcriptase into the host-cell DNA.
Cyclic GMP-AMP synthase (cGAS) . An intrinsic sensor of cytosolic DNA that, when activated, initiates the expression of interferondependent genes associated with the antiviral state. structure (FIG. 2) . The CA NTD contains three α-helices, which stabilize the hexameric subunits of CA 4 . CA NTD -CA CTD contacts between adjacent CA monomers further stabilize the hexameric or pentameric subunits [4] [5] [6] . This CA NTD -CA CTD interface also forms a binding pocket, which interacts with numerous cellular factors that play a part in infection and is the target of two recently described antiviral compounds 7, 8 (FIG. 2) (see below). Larger assemblies of hexamers and pentamers are held together by hydrophobic residues in the CA CTD , which provide the basis of the mature conical capsid core [4] [5] [6] . Inside this core are two copies of the viral RNA genome, NC, reverse transcriptase, integrase and viral accessory proteins [9] [10] [11] . Therefore, the capsid core is thought to perform two primary functions. First, the capsid core may act to maintain reverse transcriptase and the genome in a closed environment. Given the numerous strand transfers necessary to convert the viral RNA genome to doublestranded DNA, an intact core might ensure the efficient initiation of reverse transcription and effective elongation of the nascent viral DNA genome 12 . Second, the core acts to shield the viral genome from host factors that are capable of recognizing cytosolic DNA (for example, cyclic GMP-AMP synthase (cGAS; also known as MB21D1) [13] [14] [15] and three-prime repair exonuclease 1 (TREX1) 16 ).
HIV-1 uncoating
Historically, HIV-1 uncoating has been considered from a structural perspective and defined as the process by which the capsid core dissociates from the rest of the reverse transcription complex (RTC) 17 . However, it is increasingly clear that CA and the assembled capsid core provide critical functionality at numerous steps of infection. For example, CA confers the ability to infect non-dividing cells, a property that separates lentiviruses such as HIV-1 from simple retroviruses 18, 19 . Furthermore, some studies suggest that CA remains associated with the RTC following its translocation into the nucleus [20] [21] [22] [23] [24] . According to previous definitions of uncoating, the association of CA with the RTC complex in the nucleus HIV-1 infection is initiated by the binding of the viral envelope (Env) glycoprotein to the CD4 receptor and the chemokine co-receptor C-C chemokine receptor 5 (CCR5) or C-X-C chemokine receptor 4 (CXCR4) on the cell surface. This interaction results in fusion of the viral and cellular membranes and release of the viral capsid core into the cytoplasm. At this point, the virus begins reverse transcription, through which it converts its RNA genome into the double-stranded DNA genome that ultimately integrates into the host cell chromosome. This viral complex is referred to as the reverse transcription complex (RTC). During this time, the viral capsid core uses the microtubule network of the host cell to traffic towards the nucleus. Following arrival at the nucleus, the pre-integration complex (PIC, which contains the viral genome) traffics through the nuclear pore complex (NPC) in a process that is dependent on the viral capsid protein (CA), although the precise interactions mediating this step, and the state of the viral capsid core during this step, are unclear. Following nuclear import, the completely transcribed viral genome is inserted into the host cell chromosome. This integrated provirus is then responsible for the expression of viral proteins necessary for the generation of progeny virions from the infected cell. MA, matrix protein; NC, nucleocapsid protein. 
Reverse transcription complex
(RTC). The term used for viral ribonucleoprotein after it has entered the target cell and begun reverse transcription of its RNA genome. As reverse transcription is thought to initiate rapidly after fusion, we use this term to generically describe the infectious viral complex following fusion.
Simple retroviruses
Basic retroviruses, such as murine leukaemia virus, that contain only the genes gag (which encodes viral structural proteins, such as matrix and capsid), pro (which encodes the viral protease), pol (which encodes the reverse transcriptase and integrase proteins) and env (which encodes the viral protein envelope). would imply that uncoating is incomplete until the viral genome has entered the nucleus. However, studies examining the size constraints of cargos that traffic through the nuclear pore complexes (NPCs) have found an upper limit of ~39 nm 25, 26 , which is significantly smaller than the 50-60 nm width of an intact fullerene cone 4 . Taken together, this suggests that the loss of CA from the RTC is unlikely to be a single, discrete event, thereby forcing some reconsideration of the definition of uncoating. Based on the putative function of CA and the capsid core during infection, the uncoating process can be thought of as occurring in at least two stages. The first stage is the loss of integrity of the intact core. This event is necessarily cytoplasmic, as the capsid core is too large to remain intact as it traffics through the NPC. However, the recent observation that some CA remains associated with the RTC in the nucleus 23, 24 suggests that whatever core destabilization that occurs before nuclear import does not remove all of the CA from the RTC.
Nuclear pore complexes
Understanding the manner in which disassembly of the capsid core is coupled to critical aspects of infection is more than a problem of nomenclature. An intact capsid core, housing the viral genome and viral proteins, may represent a fundamentally different therapeutic target to the small amount of CA that may remain associated with the RTC following entry into the nucleus, although both may be viable therapeutic targets. Some host cell proteins, or antiviral drugs, that interact with CA may do so only in the context of assembled CA, or they may exhibit increased affinity for the assembled form of CA 7, 8 . Therefore, it is important to determine to what extent assembled CA hexamers or pentamers continue to exist following partial disassembly of the original capsid core structure.
Much of our understanding of the stability of the capsid core is derived from studies of CA mutations that perturb this stability. In this regard, it is important to separate mutations that directly alter core stability from those that may indirectly affect core stability through altered interactions with certain host factors that facilitate uncoating
. For example, in vitro studies have identified CA mutations that increase or decrease the intrinsic stability of the core, and both types of mutations reduce or abrogate HIV-1 infectivity 12 , suggesting that the intrinsic stability of the capsid core is delicately balanced to promote infection. However, the identification of compensatory mutations that improve infectivity of hyperstable or unstable CA mutants without restoring the stability of the mutant capsid core to levels similar to the wild-type capsid core 27 demonstrate the complex relationship between core stability and infection.
An improved understanding of the links between CA, the stability of the capsid core and HIV-1 infectivity is increasingly necessary, given the growing evidence that assembled CA may provide a strong target for therapeutic intervention. Unlike HIV-1 enzymes, CA is genetically 'fragile' (REF. 28 ), as it is stretched to the limit genetically by the pressure to mature into a core of optimal stability 12 , to maintain the ability to interact with numerous host factors at critical steps of infection, and to avoid interactions with capsid-targeting restriction factors designed to inhibit infection 29 . This means that CA does not have the genetic flexibility frequently used by viral proteins such as reverse transcriptase or protease to evade therapeutic strategies, as any mutation in CA is very likely to significantly and detrimentally affect the ability of CA to execute its critical functions 28 . Notably, CA assemblies from other retroviruses exhibit remarkable structural homology to those of CA from HIV-1 (REFS 30, 31) , despite a lack of sequence homology between these proteins. This suggests that the genetic fragility of HIV-1 CA is not due to an inability to adopt the basic structural elements required to generate a retro viral capsid core, but rather reflects the delicate balance of functional burdens placed on HIV-1 CA. It is also unclear what role, if any, unassembled CA species that remain associated with the viral RTC may have in infection. There are approximately 5,000 CA monomers in the virions, but only approximately 1,500 of these monomers are used to form the capsid core 1, 4 , so there is ample CA not associated with the core that may provide an additional function 30 . Finally, CA mutations that prevent the viral core from successfully navigating critical steps of infection also activate intrinsic host defence pathways that induce production of type I interferons (IFNs) and the so-called 'antiviral state' (REFS 14, 15) . This implies that therapeutic interventions that target CA may be efficacious through a synergistic reduction of viral infectivity and the secondary induction of an antiviral immune response that makes cells more resistant to subsequent infection.
Models of HIV-1 uncoating
The recent demonstration that CA influences late events during HIV-1 infection, including nuclear import and genome integration 21, 22, [32] [33] [34] , reveals that CA has functions beyond the simple encapsidation of the viral genome. Therefore, it is important to understand how the conical capsid core dissociates as the HIV genome progresses through reverse transcription and traffics to the nucleus for integration. Here, we describe the possible mechanisms by which core disassembly may occur and highlight the data most supportive of, and discordant with, each potential model (FIG. 3) . Notably, these models may not be mutually exclusive, and disassembly of the capsid core may vary by cell type and with the activation state of the infected cell at the time of infection.
Rapid core disassembly.
Biochemical studies examining the content of viral RTCs had suggested that CA and the conical capsid core are largely absent from RTCs isolated from cells soon after infection 35, 36 . When fractions containing the viral genome are interrogated for the presence of individual viral proteins, MA, reverse transcriptase and integrase are readily detectable, whereas comparatively little CA is observed 35, 36 . By comparison, CA from murine leukaemia virus remains much more stably associated with the viral RTC in identical assays 37 .
These data support a model in which the HIV-1 capsid core dissociates almost immediately on viral entry (FIG. 3) , and this was the prevailing view of uncoating for many years. However, several recent key observations have done irreparable harm to this model, including the observation that the viral capsid core can protect the genome from cytosolic DNA sensors [13] [14] [15] and allow the infection of non-dividing cells 18, 19 . Two very recent studies found that the factors which are thought to mediate
Box 1 | Methods of measuring uncoating
Several assays are available to measure uncoating of the HIV-1 capsid core.
In vitro core-stability assay With this method, core stability is assessed by a centrifugation approach in which whole virions are spun through a detergent layer into a sucrose gradient 12, 119 . This process removes the viral membrane and allows the determination of the relative stability of capsid cores harbouring certain mutations or following pharmacological treatment 12, 111 . This assay has been used to describe a 'stability window', in which capsid cores that are either more stable or less stable than the capsid cores from wild-type viruses exhibit severe infectivity defects 12 . However, this assay focuses on bulk populations of cores, of which only a small percentage may be infectious, and core stability in vitro may not necessarily be reflective of uncoating in vivo.
Fate of capsid assay
This assay subjects lysates from infected cells to centrifugation with a sucrose cushion, through which intact particulate capsid cores pellet, whereas soluble capsid (CA) protein or virions that remain in the vesicular compartment do not 120 . Thus, the amount of intact capsid cores that pellet following infection can be comparatively assayed. This assay was originally described as a method to measure core destabilization by the restriction factor tripartite motif-containing protein 5α (TRIM5α) 120 and has subsequently been used to assess the contribution of reverse transcription 51, 121 and microtubule trafficking to capsid uncoating 39, 78 and core stabilization by the restriction factor myxovirus-resistance 2 (REF. 122 ). As with the in vitro core-stability assay, this assay focuses on bulk populations of cores, of which only a small percentage may be infectious.
In situ uncoating assays
Imaging-based approaches have also been used to interrogate the amount of CA that remains associated with individual HIV-1 reverse transcription complexes (RTCs) following infection. This assay relies on the fluorescent labelling of viral particles in the producer cell using the GFP-Vpr fusion protein, which is incorporated into virions and remains associated with the viral RTC following fusion 35, 123, 41 . Membrane labelling is also used to identify viral particles that have fused with the target cell, focusing the analysis on cytoplasmic capsid cores 39, 42, [124] [125] [126] . The level of CA associated with individual viral RTCs can be comparatively analysed by immunofluorescence using capsid-specific antibodies. This assay was used to show that reverse transcription and microtubules facilitate HIV-1 uncoating 38, 39 . As with the methods discussed above, this method focuses on bulk populations of capsid cores, of which only a fraction may be infectious 127 .
CsA-washout assay
This assay relies on our understanding of TRIM-cyclophilin (Cyp) from owl monkeys, which uses a CypA domain to bind to CA and potently inhibit infection by HIV-1 (REF. 128 ). This restriction can effectively be turned off by addition of the drug cyclosporin A (CsA). Because CA is the target of TRIM-Cyp, insensitivity to CsA withdrawal suggests that the CA determinants of the viral core are no longer part of the viral RTC. Removal of CsA at different time points following infection can be used to determine what percentage of the infectious inoculum has become insensitive to TRIM-Cyp, allowing the half-life of uncoating to be calculated experimentally 38 . This assay is unique among the currently available assays of uncoating as it monitors the uncoating of virions that would otherwise go on to infect the cell, whereas the other available assays necessarily analyse the relative stability of all cytoplasmic viral complexes, many of which might not be infectious. This assay has been used to measure the contribution of reverse transcription 38 and microtubules 39 to uncoating. However, conditions that substantially alter end-point infectivity can make relative uncoating half-life comparisons open to many interpretations. Also, because uncoating is being indirectly sensed by a CA-binding restriction factor, it is possible that host factors may compete with TRIM-Cyp for a limited number of CA binding sites 47 .
the nuclear import of the RTC bind to a pocket present only on assembled CA 7, 8 , effectively closing the book on the idea that the core completely disassembles soon after viral entry.
Cytoplasmic uncoating. Several studies support the notion that a significant amount of CA is lost from the viral RTC as it undergoes reverse transcription and traffics towards the nucleus (FIG. 3) . The cyclosporin A (CsA)-washout assay -which exploits the binding of the tripartite motif-containing protein-cyclophilin (TRIM-Cyp) restriction factor to CA
-was used to measure uncoating, finding that HIV-1 gradually becomes insensitive to TRIM-Cyp binding in the first 3-4 hours after infection, with a half-life of less than 1 hour [38] [39] [40] . Although it is unclear how much CA needs to be lost for the capsid core to become insensitive to TRIM-Cyp restriction, the loss of sensitivity in this time window suggests that CA is gradually lost from the capsid core during this time.
The idea of significant core disassembly or remodelling occurring in the first hours after infection is also supported by immunofluorescent interrogation of individual cytoplasmic viral complexes
. Approximately twothirds of cytoplasmic RTCs, identified by the incorporation of fluorescent nucleotides, contain detectable amounts of CA at 4 hours post-infection 41 . A similar loss of CA from viral RTCs, identified by 5-ethynyl uridinelabelled RNA, was also observed 1-2 hours following infection 42 . Notably, these early measurements of uncoating precede the completion of reverse transcription, which normally peaks 8-12 hours after infection 38, 39, 43 and before the viral RTC has been observed within the nucleus 44 . These differences in uncoating kinetics suggest that some degree of uncoating occurs before the completion of reverse transcription, which is typically considered to be a cytoplasmic event, and before the arrival of the RTC at the NPC.
However, the perceived purpose of the viral capsid core during infection presents fundamental obstacles to this gradual model of uncoating. If the purpose of the core is to protect the genome from host DNA sensors or other restriction factors, or to provide a closed environment that facilitates reverse transcription, how can this be achieved in cores that begin to shed this protective coat in the first hours after fusion? The loss of core integrity might be expected to be coincident with the first detectable loss of CA from the capsid core, and such a loss of integrity would seemingly abrogate the protective function of the core. For example, it was recently reported that some CA mutations induce IFN responses during infection, potentially owing to activation of cytosolic DNA sensors that recognize HIV-1 DNA 15 . Activation of the IFN response by these mutant viruses, but not by the wild-type virus, is interpreted to indicate that the wild-type virus is able to keep the viral genome sequestered away from these sensors. This observation supports a protective role for the capsid core and is difficult to rationalize in a model in which CA is gradually lost from the RTC. It is unclear how the CA assembly that forms the intact capsid core could tolerate Figure 3 | Models of viral uncoating. Experimental evidence suggests three potential mechanisms by which uncoating of the viral capsid core of HIV-1 might occur. a | Early biochemical studies suggested that core disassembly occurred rapidly and relatively completely soon after HIV-1 fusion with the plasma membrane (immediate uncoating) 35, 36 . b | Other studies, including several imaging-based approaches, support a model in which some core disassembly occurs in the cytoplasm but a measurable amount of the viral capsid (CA) protein remains associated with the reverse transcription complex (RTC), which mediates association with critical host factors and nuclear import (cytoplasmic uncoating) 38, 42 . c | Additionally, other studies support the alternative notion that the core remains intact until it arrives at the nuclear pore complex (NPC), allowing it to protect its replicating genome from cytosolic DNA sensors (NPC uncoating) 14, 15 . Both the cytoplasmic uncoating and NPC uncoating models can support the finding that some level of CA remains associated with the pre-integration complex (PIC) in the nucleus 20, 22, 23 . the loss of a substantial amount of this assembly and still maintain these protective functions without becoming destabilized. It is certainly possible that other cellular factors are recruited to the RTC or pre-integration complex (PIC) in a CA-dependent fashion, and that these factors afford the protection that masks viral nucleic acids from antiviral sensors 45, 46 . Validation of this gradual model of viral uncoating will require that these critical issues be addressed.
Cores at the pores. Other studies support a model in which an intact capsid core arrives at the NPC and uncoating is functionally tethered to the nuclear import of the viral RTC 47 (FIG. 3) . The primary support for this model stems from the observation that viral cDNA generated during infection is not normally recognized by the antiviral DNA sensor cGAS 13, 14 . CA mutations that inhibit the association of the RTC with certain cellular factors have also been reported to increase innate sensing and IFN production in infected macrophages (see below) 15 . The simplest mechanism by which CA might protect the viral genome from innate sensors such as cGAS is that the capsid core remains intact until disassembly occurs at the NPC, triggered by CA-associating factors. Electron micrographs of apparently intact cores at the NPC support the possibility that the separation of the viral genome from intact cores may occur at nuclear pores 44 . However, issues of timing and discordance with other studies require that this model be approached cautiously. For example, the intact cores observed at the NPC were found at late timepoints after infection (up to 48 hours post infection), timepoints that are later than core disassembly, the completion of reverse transcription and nuclear localization have been measured in other assay systems 38, 39, 41, 42 
. Finally, this model is inconsistent with the finding that CA mutations that increase core stability prevent reverse transcription 12 , as these data suggest that some core remodelling must occur during reverse transcription in the cytoplasm. Therefore, validation of a model in which intact cores dock at the NPC to avoid viral detection by cytosolic sensors should address these problems.
Viral and cellular determinants of uncoating
One fact that has made understanding the uncoating process difficult is that it is an aspect of the viral lifecycle that occurs concurrently with, and is in many ways contingent on, other aspects of the viral lifecycle. As such, uncoating may not only be influenced by interactions between CA and specific host factors but may also be regulated in a spatiotemporal fashion by interactions driving other aspects of the viral lifecycle. Here, we describe the steps of the viral lifecycle and cellular proteins that have been implicated in the uncoating process or other CA-dependent steps of infection.
Viral determinants of uncoating.
Numerous lines of evidence now suggest that events or interactions within the viral capsid core can affect the uncoating process. For example, deletion or mutation of the viral integrase has been shown to have effects much earlier in the lifecycle than during the integration step itself 48, 49 . Specifically, certain point or deletion mutations of integrase completely abrogate reverse transcription in the target cell, and these viruses generate capsid cores that are less stable than wild-type cores, both in vitro and in vivo 48 . Taken together with the observation that integrase mutations can affect the morphology of HIV-1 cores 50 , these data support a model in which integrase provides stability to the core from inside the virion, which facilitates its association with cytoplasmic factors, such as CypA 48 (FIG. 4) (see below) .
Two studies have also found that inhibition of reverse transcription delays uncoating. This observation was first made using the CsA-washout assay and in situ uncoating assays 38 , and was subsequently corroborated using the fate of capsid (FOC) assay, which measured an increase in the amount of intact capsid in the presence of reverse transcriptase inhibitors or when reverse transcriptase was genetically inactivated 51 
. These observations support a model in which the formation of nascent, polymerized viral DNA induces stress on the structure from within the core (FIG. 4) . It is known that CA mutations that form hyperstable cores exhibit a severe defect in reverse transcription 12 , which is consistent with the hypothesis that the progression of reverse transcription requires, and normally induces, some degree of core remodelling necessary to accommodate the viral genome as it converts from relatively flexible single-stranded RNA to comparatively rigid doublestranded DNA. Alternatively, these data are also consistent with a model in which interactions between reverse transcriptase and integrase cooperatively stabilize the core 52 (FIG. 4) . In such a model, the onset of reverse transcription may dissociate the viral reverse transcriptase from these stabilizing interactions, which might explain the relevance of both reverse transcriptase and integrase to the uncoating process.
CypA. CypA is a host peptidyl prolyl isomerase that has, for more than 20 years, been known to interact with CA [53] [54] [55] . Although CypA can be incorporated into virions 53, 55 , the more biologically relevant interaction seems to occur in the cytoplasm of the target cell, where CypA can promote infection in some cell types 56-59 through interaction with a conserved proline-rich loop present on the HIV-1 CA 53, 55, 60 . CypA knockdown, genetic deletion and inhibition with the immunosuppressive drug CsA (which inhibits CypA activity) inhibit an early step in infection that alters normal reverse transcription 55, [61] [62] [63] . However, CsA inhibition of CypA is incomplete and is cell type-dependent 64, 65 . CypA has been shown to catalyse the cis-trans isomerization of the Gly89-Pro90 peptide bond of CA 66 , and this isomerization has been shown to induce conformational changes in residues in the CA NTD that are distal to the CypA-binding loop 66 . In the context of an assembled CA lattice, it is tempting to speculate that CypA-induced conformational changes in CA may provide the mechanistic basis for disassembly of the capsid core (FIG. 4) . However, data supporting this hypothesis are contradictory, with one study observing in vitro destabilization of CA-NC complexes 67 and a different study finding that CypA has the opposite effect, stabilizing viral cores in vitro 68 . The role of CypA during capsid uncoating is additionally complicated by the phenotype of mutants generated though continuous replication in the presence of CsA 61, [69] [70] [71] . Mutations that allow for robust replication in the presence of CsA are also dependent on the presence of CsA for their replication in some cells 61, 69, 72 , whereas in other cells these mutations confer CsA resistance but not dependence 56, 57, 61, 64, 65 . CsA-resistant or CsA-dependent viruses still bind CypA 61, 65 , and expression levels of CypA can influence infection by these mutants 65, 73, 74 . Collectively, these observations make it difficult to assign a single, critical role to CypA in the uncoating process, although it seems clear that CypA plays an essential part in uncoating or in some aspect of infection that occurs concurrently with uncoating. In this regard, it is also important to note that most CsAresistant mutants are also unable to efficiently infect non-dividing cells 72, 74 , suggesting a previously unappreciated link between CsA resistance and the ability to infect non-dividing cells 64 . Understanding this phenotype may allow a better understanding of the role of CypA in natural infection.
Cytoplasmic trafficking. Studies of fluorescently labelled HIV-1 viral particles have found that HIV-1 virions use dynein-dependent trafficking to move towards the nucleus during infection 41, 75 , and perturbing micro tubulemediated trafficking or depleting microtubule motor proteins inhibits HIV-1 infection 39, 76, 77 . Recently, two studies found that microtubule disruption and knockdown of microtubule motors delays uncoating of the viral capsid core (FIG. 5) . The first study used the CsA-washout assay, the in situ uncoating assay and the FOC assay (BOX 1) to demonstrate a delay in uncoating when microtubules were disrupted or when dynein heavy chain or kinesin-1were depleted 39 . The second study 78 used the FOC assay to demonstrate that dynein depletion or inhibition delays uncoating. Therefore, it is possible that these observations reflect a 'tug-of-war' model of cytoplasmic uncoating of the viral core, in which uncoating is mediated by the opposing motor proteins dynein and kinesin-1 (FIG. 5) . However, it is worth noting that uncoating of adenovirus is also mediated by both dynein and kinesin-1 but occurs at the NPC, rather than in the cytoplasm 79 . Therefore, the data in these studies do not preclude a similar two-stage mechanism of HIV-1 core uncoating at the NPC, in which dynein is required for trafficking of the capsid core to the NPC and kinesin-1 is responsible for viral uncoating at the NPC (FIG. 5) . However, this model would seem to require the arrival of the capsid core at the NPC with faster kinetics than were reported in studies that observed intact cores at the NPC 44 .
Determinants of HIV-1 nuclear import
As a lentivirus, HIV-1 possesses the ability to infect nondividing cells, whereas most other retroviruses require cell division and the breakdown of the nuclear envelope to access target cell DNA and complete infection. Simultaneously, or perhaps alternatively, CypA binding may prevent the interaction between the capsid core and a cryptic restriction factor 57, 130, 131 . Env, envelope; MA, matrix protein; NPC, nuclear pore complex; NUP153, nucleoporin 153; NUP358, nucleoporin 358; PIC, pre-integration complex. 
Kinesin-1
A motor protein that couples ATP hydrolysis with mechanical movement of cargos, in a manner similar to dynein. However, unlike dynein, there are many types of kinesins, and these motors typically traffic cargos towards the plus ends of microtubules, away from the nucleus.
Although previous studies implicated numerous viral determinants as being responsible for the ability to infect non-dividing cells, more recent data provide compelling evidence that CA is involved in mediating the nuclear translocation of the viral genome 18, 19, 80 . This appreciation was rapidly followed by the identification of numerous cellular proteins, including components of the NPC, that interact with CA and are associated with trafficking from the cytoplasm to the nucleus [81] [82] [83] [84] . These interactions drive critical steps of infection and, as such, have clearly demonstrated that some CA, in its assembled form 7, 8 , remains associated with the RTC during this stage of infection. Here, we describe the cellular factors implicated in this process (reviewed in detail in REF. 85 ).
Capsid interaction with CPSF6. Cleavage and polyadenylation specificity factor 6 (CPSF6) is an mRNAprocessing protein that shuttles between the nucleus and cytoplasm 23 . A serine/arginine (SR)-rich nuclearlocalization signal on its C terminus maintains a predominately nuclear steady state localization 23, 86 , although the protein shuttles dynamically between the nucleus and cytoplasm 87 . However, a study using a mouse cDNA-expression screen found that a truncated form of CPSF6 (CPSF6 , which is missing its C-terminal SR-rich domain and is therefore predominately cytoplasmic) potently inhibited infection by HIV-1 (REF. 83 ). Inhibition of infection by mouse CPSF6 was observed against other primate . b | Alternatively, dynein-mediated trafficking may be necessary to facilitate the interaction between the capsid core and components of the nuclear pore complex (NPC). Engagement of NPC components, such as nucleoporin 358 (NUP358), might directly induce uncoating 99, 105 . However, these factors may act to anchor the core at the NPC while the engagement of the core by kinesin motor proteins provides the force necessary for core destabilization 39 . CA, capsid protein; Env, envelope; MA, matrix protein; PIC, pre-integration complex; RTC, reverse transcription complex. Two-long-terminal-repeat circles (2-LTR circles). Loops of genome and LTRs. The completely reverse-transcribed HIV-1 genome is flanked on either side by LTRs, which ultimately define the genomic boundaries of the provirus following successful integration. At a low frequency, the cellular non-homologous end joining (NHEJ) repair pathway joins the LTRs, resulting in 2-LTR circles. As the NHEJ pathway is active only in the nucleus, the presence of 2-LTR circles is used as a surrogate for nuclear entry of the pre-integration complex.
lentiviruses, such as HIV-2 and SIV, but not against murine leukaemia virus, a gammaretrovirus that cannot infect non-dividing cells 83 , suggesting that CPSF6 plays a part in the ability of primate lentiviruses to infect non-dividing cells. In cells expressing mouse CPSF6 , reverse transcription occurs normally but the formation of two-long-terminal-repeat circles (2-LTR circles) is inhibited and functional PICs accumulate in the cytoplasm, consistent with a defect in nuclear entry induced by CPSF6 1-358 (REF. 83) . A similar restriction was observed with a truncated form of human CPSF6, although notably this human form inhibited infection at an earlier step, before reverse transcription 88 . At the level of the virus, CPSF6 1-358 -mediated restriction clearly mapped to CA, as a CPSF6 1-358 -resistant mutant virus was revealed to harbour a mutation in CA (N74D, in which asparagine is replaced by aspartic acid) 83 and CPSF6 was able to bind to in vitro assembled CA tubes 83, 86, 89 . The interaction between CPSF6 1-358 and CA was also supported by other studies, which found that cytoplasmic CPSF6 stabilized viral cores in vivo 90 and CA-NC tubes in vitro 67 . The CA-binding determinants in CPSF6 have been identified 91 and shown to interact with the binding pocket in assembled CA, which is formed by intermolecular interactions between the CA CTD and CA NTD of neighbouring CA molecules 7, 86 (FIG. 2) . Given the inhibitory effects mediated by CPSF6 , which is generated by removal of the nuclear-localization signal from CPSF6, it seems likely that full-length CPSF6 has a role in mediating the nuclear import of the RTC, although this has yet to be formally demonstrated.
Capsid interaction with TNPO3. Three genome-wide small interfering RNA screens for cellular factors required for HIV-1 infection identified transportin 3 (TNPO3) as facilitating a late stage of HIV-1 infection 81, 82, 84 . TNPO3 is a member of the importin-β family of proteins, which governs the nuclear localization of SR-rich proteins 92 . Several studies have revealed that TNPO3 can bind to the viral integrase [93] [94] [95] [96] . Although this interaction seems to be robust and has been reproduced by various studies, this binding does not seem to be sufficient to explain the dependence of HIV-1 infection on TNPO3 (REFS 94, 95) . Instead, the dependence of HIV-1 infection on TNPO3 maps to determinants in CA 95 . Initial studies showed that TNPO3 depletion reduces the amount of viral integration but does not reduce viral reverse transcription or 2-LTR circle formation 20, 68, 97, 98 . However, this has been shown to be primarily due to the inability of the PCR primers typically used for the amplification of 2-LTR circles to distinguish between bona fide 2-LTR circles and auto-integration events 90 . This study demonstrated that TNPO3 depletion does indeed inhibit 2-LTR circle formation, which has also been reported by other studies 99, 100 . Remarkably, numerous studies observed that, although infectivity of wild-type HIV-1 was potently inhibited by TNPO3 knockdown, infection by the N74D CA mutant 83 was unaffected by TNPO3 depletion 20, 68, 83, 97, 98 . Furthermore, TNPO3 also seems to bind to HIV-1 CA 20, 98 . Collectively, these studies suggest that TNPO3 participates in the nuclear translocation of the viral RTC. The ability of TNPO3 to facilitate the nuclear translocation of the RTC might be attributable to one of two mechanisms. First, TNPO3 may affect HIV-1 nuclear import directly by binding to CA. Given the resistance of the N74D mutant to TNPO3 depletion, this may occur at the same CA binding sight bound by CPSF6. Alternatively, TNPO3 may affect HIV-1 nuclear import indirectly by mediating the proper nucleoplasmic localization of other proteins relevant to the nuclear import of the RTC, such as CPSF6, as suggested by its ability to regulate the localization of SR-rich proteins 92 .
Capsid interaction with NPC proteins. Nuclear pores are large (~50 mDa) complexes that regulate nucleocytoplasmic trafficking in all eukaryotic cells (reviewed in REFS 101, 102) . Two components of NPCs, nucleoporin 358 (NUP358; also known as RANBP2) and NUP153, were identified in genome-wide screens for cellular factors required for HIV-1 infection 81, 82, 84 . NUP358 is a component of nuclear pore filaments, which project outwards towards the cytoplasm from the NPC and, like many other NPC channel proteins, possess phenylalanine/glycine repeats that form a hydrophobic meshwork that regulates traffic of molecules above ~40 kDa across the pore 101, 102 . NUP358 depletion attenuates HIV-1 infectivity, typically threefold to eightfold 99, 103, 104 , with most studies observing normal reverse transcription and reduced 2-LTR circle formation, suggesting that NUP358 depletion prevents the efficient nuclear import of the RTC 82, 99, 100, 103 . Notably, NUP358 also possesses a CypA-homology domain, which has been shown to interact with viral CA 99 and induce CA isomerization 105 , suggesting that NUP358-mediated isomerization of CA induces core uncoating (FIGS 3, 5) . However, other studies have found that NUP358-mediated enhancement of HIV-1 infectivity is independent of the CypA-homology domain 104 , leaving the mechanism by which NUP358 engages HIV-1 unclear.
NUP153 is also present in the NPC and is conceptually similar to NUP358, although NUP153 is localized to the nuclear side of the NPC and its filaments containing phenylalanine/glycine repeats extend into the nucleoplasm, rather than into the cytoplasm 101, 102 (FIGS 3, 5) .
The dependence of HIV-1 infection on NUP153 maps to viral CA 21 , and NUP153 has been shown to interact with CA 7, 8, 22, 32 , notably relying on the same binding pocket in CA that is required for many other interactions with nuclear-import pathway factors. Notably, despite the localization of NUP153 to the nuclear side of the NPC, NUP153 knockdown reduces the formation of 2-LTR circles 21, 32, 103 . As 2-LTR circles are considered a marker of PIC arrival to the nucleus and NUP153 is generally considered a nucleoplasmic pore protein, this result is counterintuitive. Taken at face value, this would suggest that, following arrival at the nucleoplasmic side of the NPC, a NUP153-dependent process completes some final step that is necessary to activate the integration activity of the PIC. Alternatively, it is worth considering that both NUP358 and NUP153 dynamically associate with the NPC 79, 106 , and that NUP358 is known to be a critical adaptor of kinesin-1 (REF. 107 ). Thus, it is possible that these NUP-dependent effects are driven by interactions between CA and the NPC in the cytoplasm, which could be necessary for the subsequent nuclear translocation of the viral genome. Additional experiments are necessary to distinguish between these two possibilities.
CA determinants dictate late events in infection
The current understanding of the role of the capsid core and CA in the steps culminating in the integration of the HIV genome into the genome of the host cell is confounded by multiple observations suggesting that the intact capsid core no longer exists in its initial, conical state in the first few hours after infection 38, 39, 41, 42 , yet determinants in CA can influence nuclear-import pathways and integration-site selection [32] [33] [34] 83 . The idea that the capsid core must disassemble before nuclear import while the binding pocket formed by assembled CA remains associated with the RTC in the nucleus, where it mediates interactions that dictate the final steps of infection, is a paradox that can be explained in several ways.
One possibility is that the recruitment of cellular factors to the viral core facilitates some degree of core disassembly while also influencing the subsequent engagement of other host factors that mediate the nuclear import and integration of the genome. For example, although NUP153-dependent steps are essential for HIV-1 infection, NUP153 dependence was lost when cells were infected in the presence of CsA or when CypA was depleted 21 . Similarly, viral mutants carrying the CypAbinding mutations G89V (in which glycine is replaced by valine) and P90A (in which proline is replaced by alanine) in CA are less sensitive than wild-type virus to NUP153 depletion 21, 90, 99 . These data suggest that early engagement of host factors in the cytoplasm can dictate the final CA-dependent steps of infection in the nucleus, although our understanding of how this is achieved remains incomplete. It is possible that CypA engagement of the capsid core facilitates a minimal level of disassembly that is required for subsequent NUP153 interaction. Alternatively, CypA binding may protect the capsid core from binding other factors that would otherwise drive the virus down an alternative import pathway that is not reliant on NUP153. A similar possibility is supported by the observation that a slower rate of uncoating is shown by HIV-1 that contains CA mutations associated with alternative nuclear-import pathways and the inability to infect non-dividing cells (as measured with the CsA-washout assay) 108 . Furthermore, the decreased rate of capsid uncoating can vary between different CA mutations. For example, HIV-1 with the Q63,67A CA mutation (in which glutamine is replaced in two places by alanine) exhibits a long delay in uncoating, whereas viruses with E45A (in which glutamic acid is replaced by alanine) and N74D CA mutations show less-dramatic delays. However, the viral reverse transcriptase can polymerize nucleotides at rates up to 4 nucleotides per second, so a 10-20 minute delay would present a very different structure as a more developed or mature RTC becomes accessible to cytoplasmic cellular factors that bind to the complex. In this way, determinants in CA could influence the timing of uncoating, and delayed uncoating could lead to association with a different series of factors involved in nuclearimport pathway selection. This could be especially important in the infection of certain cell types that are known to have very low levels of the deoxyribose nucleoside 5ʹ-triphosphates necessary for reverse transcription, such as macrophages and resting T cells 109 . It also seems increasingly likely that a small amount of assembled CA remains associated with the RTC during nuclear translocation. Numerous studies now support the notion that many of the factors relevant to nuclear import, including CPSF6 and NUP153, bind to a conserved binding pocket formed by intermolecular CA NTD -CA CTD interactions in assembled CA 7, 8, 22, 83, 86 . CPSF6 binding to this pocket, for example, seemingly must include a nuclear phase, as mutations that render CPSF6 exclusively cytoplasmic generate an antiviral protein 91 . Consistent with this model, two imaging-based studies have recently observed CA associated with nuclear HIV-1 complexes 23, 24 . How this small amount of CA remains in the complex after uncoating remains a critical question. It is also notable that these two factors, the timing of cellular factor accessibility to the disassembled capsid core and the observation that small amounts of CA remain associated with the RTC, are not mutually exclusive and could both influence late steps in infection, such as nuclear-import pathways and integration-site selection.
One potential problem related to the small amount of CA that remains associated with the RTC is that it seems unlikely that there would be enough binding sites in CA for all of the CA-binding host factors, such as CPSF6, the NUPs and TNPO3. However, binding could be sequential, or some of the factors might function primarily to influence other host factors, as with the possibility mentioned above that TNPO3 functions to regulate the localization of CPSF6. Alternatively, sufficient binding sites may be present to allow the simultaneous binding to different sites. These possibilities seem intrinsically testable with the concerted use of the current toolbox of uncoating assays
.
CA as the target of new antiviral compounds
The potential value of understanding the uncoating process and the role of assembled CA during infection is underscored by the identification of two pharmacological inhibitors of HIV-1 infection that seem to modulate the stability of the capsid core and the ability of CA to interact with critical host factors during infection. The compound PF74 was originally identified in a high-throughput screen as a small-molecule inhibitor of HIV-1 infection targeting the viral CA protein 110 , and initial analysis suggested that PF74 could destabilize the capsid core in vitro 111 . Subsequent studies have observed a more nuanced mechanism of action of this drug, with core destabilization possibly occurring at higher drug concentrations, while potent inhibition is also observed at lower concentrations that, if anything, seem to stabilize the viral core 7, 8, 67 . Perhaps unsurprisingly, this compound targets the same binding pocket in assembled CA required for binding to CPSF6 and NUP153 (REFS 7,8,22,86 ).
Another compound, BI-2 (REF. 112 ), targets similar regions of CA 8, 112 , with the interesting nuance that, unlike PF74, this compound destabilizes viral cores in the low range of effective concentrations 113 and its binding pocket does not span the CA NTD -CA CTD interface 8 . As BI-2 binding can inhibit CPSF6 binding 113 , these differences between BI-2 and PF74 might provide tools with which to separate the uncoating process from the requirement to engage specific cellular factors, such as CPSF6 or NUP153, during infection. In agreement, one recent study has observed that HIV-1 remains susceptible to both PF74 and BI-2 for hours after some degree of uncoating has occurred, as measured by the CsA-washout assay 24 .
Outlook
Although still incomplete, our developing understanding of the interactions occurring between host factors and CA during infection provides ample support for the notion that these interactions can provide therapeutic opportunities. In this regard, an understanding of the events driving the disassembly of the viral capsid core and how these events are spatiotemporally regulated during infection may afford new or improved opportunities to inhibit infection.
Understanding these steps may have important therapeutic implications. Targeting CA therapeutically may provide the added benefit of inducing IFN-stimulated genes that activate the so-called antiviral state, making cells more resistant to subsequent infection 14, 15 . Recent studies suggest that activation of these pathways allows better viral control in patients following interruption of antiretroviral therapy 114 and in rhesus macaque SIV models 115 . However, chronic activation of these pathways and the inflammation this causes are typically associated with the opposite effect in patients [115] [116] [117] .Therefore, effective CA-targeting strategies may activate IFNs in a way that is specific to the tissue in which HIV-1 is attempting to replicate in a temporally appropriate manner.
It is also important to consider that targeting the primary nuclear-import pathway used during infection may increase the ability of the virus to use alternative import pathways 83 , which in turn may have therapeutic consequences. Perturbing interactions with host factors that act during the late steps of the early phase of the viral replication cycle, such as TNPO3, NUP153 or NUP358, can alter the range of integration sites used by the virus, driving integration away from transcriptionally active regions towards intergenic, transcriptionally silent regions of DNA [32] [33] [34] . Thus, treatment may make infection less efficient but also may lead to more integrations in transcriptionally silent regions, resulting in an increase in the reservoir of latently infected cells during the course of infection 118 . These are important considerations for CA-targeted therapeutic opportunities moving forward, which seem likely to increase in number as our understanding of the basic science of CA during infection continues to develop.
